CT
Corcept Therapeutics Incorporated
🇩🇪XSTU.HTDGermanyHealthcare
€97.44EURup +1.96 (+2.05%)ClosedEnd of day5:19 AM
Price€97.44+1.96 (+2.05%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US2183521028
- CUSIP
- Not reported
Company
- Employees
- 730
- Headquarters
- Redwood City, United States
- Website
- https://www.corcept.com
- CEO
- Dr. Joseph K. Belanoff M.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- $0.46
- P/E LTM
- 187.51
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $830.81M+16.02%up year on year
- Net income
- $54.9M-58.66%down year on year
- Gross margin
- 98.3%-0.07%down year on year
- Free cash flow
- $106.92M-40.69%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.